Expression of miR-203 and its target genes in condyloma acuminatum and their relationships with clinical recurrence

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Plotzker RE, Vaidya A, Pokharel U, Stier EA. Sexually transmitted human papillomavirus: update in epidemiology, prevention, and management. Infect. Dis. Clin. North Am. 37(2), 289–310 (2023).
  MedlineGoogle Scholar
• 2. Sindhuja T, Bhari N, Gupta S. Asian guidelines for condyloma acuminatum. J. Infect. Chemother. 28(7), 845–852 (2022).
  MedlineGoogle Scholar
• 3. Ure A, Mukhedkar D, Arroyo Mühr LS. Using HPV-meta for human papillomavirus RNA quality detection. Sci. Rep. 12(1), 13058 (2022).
  Medline CASGoogle Scholar
• 4. Serrano B, Brotons M, Bosch FX, Bruni L. Epidemiology and burden of HPV-related disease. Best Pract. Res. Clin. Obstet. Gynaecol. 47, 14–26 (2018).
  MedlineGoogle Scholar
• 5. Zhu P, Qi RQ, Yang Y et al. Clinical guideline for the diagnosis and treatment of cutaneous warts (2022). J. Evid. Based. Med. 15(3), 284–301 (2022).
  MedlineGoogle Scholar
• 6. Giuliano AR, Sirak B, Abrahamsen M et al. Genital wart recurrence among men residing in Brazil, Mexico, and the United States. J. Infect. Dis. 219(5), 703–710 (2019). •• This reflects the high recurrence rate of CA.
  MedlineGoogle Scholar
• 7. Hu S, Yang Y, Jiang B et al. Treatment of condyloma acuminatum using the combination of laser ablation and ALA-PDT. Photodiagnosis Photodyn. Ther. 25, 193–196 (2019).
  Medline CASGoogle Scholar
• 8. Sugai S, Nishijima K, Enomoto T. Management of condyloma acuminata in pregnancy: a review. Sex. Transm. Dis. 48(6), 403–409 (2021).
  Medline CASGoogle Scholar
• 9. Hu Y, Hu E, Su X, Chen X, Tao X, Ren X. Molecular mechanism of microRNA-26a regulation of phosphatase and tensin homolog gene in condyloma acuminatum and penile squamous cell carcinoma. J. Int. Med. Res. 49(7), 3000605211014379 (2021).
  Google Scholar
• 10. Wu S, Lu D, Zheng X et al. Dysregulation of autophagy-associated microRNAs in condyloma acuminatum. Infect. Genet. Evol. 93, 104878 (2021). • This study was designed to identify autophagy-related miRNAs and their targets in CA and to validate their expression.
  Medline CASGoogle Scholar
• 11. Yi R, Poy MN, Stoffel M, Fuchs E. A skin microRNA promotes differentiation by repressing ‘stemness’. Nature 452(7184), 225–229 (2008).
  Medline CASGoogle Scholar
• 12. Wei T, Orfanidis K, Xu N et al. The expression of microRNA-203 during human skin morphogenesis. Exp. Dermatol. 19(9), 854–856 (2010).
  Medline CASGoogle Scholar
• 13. Lin J, Wang L, Gao J, Zhu S. MiR-203 inhibits estrogen-induced viability, migration and invasion of estrogen receptor α-positive breast cancer cells. Exp. Ther. Med. 22(4), 1134 (2021).
  MedlineGoogle Scholar
• 14. Hao M, Zhao W, Zhang L, Wang H, Yang X. Low folate levels are associated with methylation-mediated transcriptional repression of miR-203 and miR-375 during cervical carcinogenesis. Oncol. Lett. 11(6), 3863–3869 (2016).
  Medline CASGoogle Scholar
• 15. Cui X, Chen X, Wang W et al. Epigenetic silencing of miR-203 in Kazakh patients with esophageal squamous cell carcinoma by MassARRAY spectrometry. Epigenetics 12(8), 698–707 (2017).
  MedlineGoogle Scholar
• 16. Chen LZ, Ding Z, Zhang Y, He ST, Wang XH. MiR-203 over-expression promotes prostate cancer cell apoptosis and reduces ADM resistance. Eur. Rev. Med. Pharmacol. Sci. 24(6), 2784 (2020).
  MedlineGoogle Scholar
• 17. Sharma G, Agarwal SM. Identification of critical microRNA gene targets in cervical cancer using network properties. Microrna. 3(1), 37–44 (2014). • It performed a systematic analysis of known dysregulated miRNAs involved in cervical cancer.
  Medline CASGoogle Scholar
• 18. Diţescu D, Istrate-Ofiţeru AM, Roşu GC et al. Clinical and pathological aspects of condyloma acuminatum – review of literature and case presentation. Rom. J. Morphol. Embryol. 62(2), 369–383 (2021).
  MedlineGoogle Scholar
• 19. Zhang S, Khosravi H, Cardis M, Jedrych J, Ho J, Bunimovich Y. A challenging diagnosis of penile sarcomatoid squamous cell carcinoma. Dermatol. Online J. 25(10), (2019).
  Google Scholar
• 20. Park S, Lee S, Kim J et al. ΔNp63 to TAp63 expression ratio as a potential molecular marker for cervical cancer prognosis. PLoS One. 14(4), e0214867 (2019). • It demonstrates the ΔN/TAp63 mRNA expression ratio could be useful as a diagnostic and prognostic marker of cervical cancer.
  Medline CASGoogle Scholar
• 21. Li F, Ambrosini G, Chu EY et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396(6711), 580–584 (1998).
  Medline CASGoogle Scholar
• 22. Yin G, Li X, Wang X, Zhang H. Effect of 5-aminolevulinic acid photodynamic therapy on the expression of apoptosis inhibitors Bcl-2 and Survivin in keratinocytes of condyloma acuminatum. Photodiagnosis Photodyn. Ther. 28, 53–57 (2019).
  Medline CASGoogle Scholar
• 23. Zhou WQ, Sheng QY, Sheng YH et al. Expressions of survivin, P16(INK4a), COX-2, and Ki-67 in cervical cancer progression reveal the potential clinical application. Eur. J. Gynaecol. Oncol. 36(1), 62–68 (2015). • Investigate the significance of survivin and P16 (INK4a) expressions in predicting the progression of cervical cancer.
  Medline CASGoogle Scholar
• 24. Al-Joudi FS, Iskandar ZA, Hasnan J et al. Expression of survivin and its clinicopathological correlations in invasive ductal carcinoma of the breast. Singapore Med. J. 48(7), 607–614 (2007).
  Medline CASGoogle Scholar
• 25. Yin GW, Li J, Zhang HB. Expression and clinical significance of apoptosis-associated proteins survivin and livin in condyloma acuminatum. J. Biol. Regul. Homeost. Agents. 29(2), 431–436 (2015).
  Medline CASGoogle Scholar
• 26. Jin J, Deng J, Wang F et al. The expression and function of microRNA-203 in lung cancer. Tumour Biol. 34(1), 349–357 (2013).
  Medline CASGoogle Scholar
• 27. Wang Y, Xu B, Shen X, Sun L. Diagnostic value of miR-153 and miR-203 in patients with cervical cancer and their correlation with human papillomavirus infection. Am J Transl Res. 13(8), 9736–9742 (2021). •• This demonstrates the diagnostic value of miR-203 in cervical cancer patients.
  Medline CASGoogle Scholar
• 28. Kim CJ, Campbell SP, Allkanjari A, Lentz AC. Update on the medical and surgical management of urethral condyloma. Sex. Med. Rev. 10(2), 240–254 (2022).
  MedlineGoogle Scholar
• 29. Kim JK, Park YG, Kim BG. Correlation between recurrence of anorectal condyloma acuminatum and human papilloma virus subtype. Genes Genom. 44(3), 389–394 (2022).
  Medline CASGoogle Scholar
• 30. Bian K, Fan J, Zhang X et al. MicroRNA-203 leads to G1 phase cell cycle arrest in laryngeal carcinoma cells by directly targeting survivin. FEBS Lett. 586(6), 804–809 (2012).
  Medline CASGoogle Scholar
• 31. Lena AM, Shalom-Feuerstein R, Rivetti Di Val Cervo P et al. miR-203 represses ‘stemness’ by repressing DeltaNp63. Cell Death Differ. 15(7), 1187–1195 (2008).
  Medline CASGoogle Scholar
• 32. Liu HP, Zhang Y, Liu ZT et al. MiR-203 regulates proliferation and apoptosis of ovarian cancer cells by targeting SOCS3. Eur. Rev. Med. Pharmacol. Sci. 24(15), 7914 (2020).
  MedlineGoogle Scholar
• 33. O'connor DS, Schechner JS, Adida C et al. Control of apoptosis during angiogenesis by survivin expression in endothelial cells. Am. J. Pathol. 156(2), 393–398 (2000).
  MedlineGoogle Scholar
• 34. Mesri M, Morales-Ruiz M, Ackermann EJ et al. Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting. Am. J. Pathol. 158(5), 1757–1765 (2001).
  Medline CASGoogle Scholar
• 35. Pokorna Z, Hrabal V, Tichy V, Vojtesek B, Coates PJ. DNA demethylation switches oncogenic ΔNp63 to tumor suppressive TAp63 in squamous cell carcinoma. Front. Oncol. 12, 924354 (2022).
  Medline CASGoogle Scholar